Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Merck Fails to Win FDA Approval on Gardasil Use in Older Women
Bloomberg
Wednesday, April 6, 2011 - 7:44pm
tags:
Merck, FDA, Gardasil, HPV
Breast-Cancer Link to Paxil Drug Category Found in Antidepressant Research
Bloomberg
Wednesday, April 6, 2011 - 7:40pm
tags:
antidepressants, SSRIs, breast cancer, Eli Lilly, Paxil, GSK, Prozac
Elan Up the Most in 3 Months After Positive Tysabri Comments
Bloomberg
Wednesday, April 6, 2011 - 7:36pm
tags:
Elan, Tysabri, bapineuzumab
Bullish Outlook For Novo Nordisk
Forbes/Zacks.com
Wednesday, April 6, 2011 - 7:34pm
tags:
Novo Nordisk
Is Celgene the Perfect Stock?
Motley Fool
Wednesday, April 6, 2011 - 7:32pm
tags:
Celgene
Millennium signs licensing pact with Sunesis Pharma
Pharmaceutical Business Review
Wednesday, April 6, 2011 - 8:40am
tags:
Sunesis, Millennium, pan-Raf, kinase inhibitors
AVI BioPharma: Recent Fund-Raising Not a Competitive Entry Point
Seeking Alpha
Wednesday, April 6, 2011 - 8:35am
tags:
AVI BioPharma
Optimer to Co-Market Dificid Drug With Cubist Pharmaceuticals
Bloomberg
Wednesday, April 6, 2011 - 8:18am
tags:
Dificid, Cubist Pharmaceuticals, Optimer, antibiotics, fidaxomicin
Novartis Aims to Resurrect ‘Zombie’ Drug After Four Years
Bloomberg
Wednesday, April 6, 2011 - 8:17am
tags:
Novartis, Europe, Joicela, painkillers, Prexige
Abbott Labs: 3 Reasons to Be Long-Term Bullish
Seeking Alpha
Wednesday, April 6, 2011 - 8:15am
tags:
Abbott Laboratories
On Novartis's Patent Dispute in India
Seeking Alpha
Wednesday, April 6, 2011 - 8:14am
tags:
India, patents, Gleevec, Novartis
10 promising late-stage cancer drugs
Fierce Biotech
Tuesday, April 5, 2011 - 10:47pm
tags:
cancer, Carfilzomib, crizotinib, vismodegib, Oncovex, PLX4032, Ponatinib, SGN-35, tivozanib, T-DM1, cabozantinib, ONYX Pharmaceuticals, Pfizer, Genentech, Curis, Amgen, Plexxikon, Seattle Genetics, Ariad Pharmaceuticals, Aveo Pharmaceutical, Exelixis, Roche
The Incredible Shrinking Eye Care Sector
Seeking Alpha
Tuesday, April 5, 2011 - 10:40pm
tags:
eye health, Allergan, Alcon, Essilor, Inspire, Ista, JNJ, Merck, Novartis, Pfizer
Apthera Acquisition Puts RXi Pharmaceuticals in New League
Seeking Alpha
Tuesday, April 5, 2011 - 10:15pm
tags:
Apthera, RXi Pharmaceuticals
Bankers expect more Japanese-led M&A in pharma
Fierce Pharma
Tuesday, April 5, 2011 - 9:58pm
tags:
M&A, Japan
Seattle Genetics shares rise in heavy trading
Bizjournals.com
Tuesday, April 5, 2011 - 9:55pm
tags:
Seattle Genetics, antibody-drug conjugate
Cephelon rejects Valeant takeover offer
Marketwatch
Tuesday, April 5, 2011 - 9:11pm
tags:
hostile bid, Valeant Pharmaceuticals, M&A, Cephalon
Cubist Soars on Settlement
Minyanville
Tuesday, April 5, 2011 - 9:10pm
tags:
Cubist Pharmaceuticals, Teva Pharmaceuticals, settlements, Cubicin
Optimer Wins FDA Panel’s Backing for Antibiotic Fidaxomicin
Bloomberg
Tuesday, April 5, 2011 - 9:06pm
tags:
Optimer, FDA, antibiotics, fidaxomicin, advisory panels
Genzyme, Isis Say Mipomersen Cut LDL-C in Two Studies
Bloomberg
Tuesday, April 5, 2011 - 10:49am
tags:
Isis Pharmaceuticals, Genzyme, mipomersen, LDL-C

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.